Matches in Nanopublications for { ?s ?p "[The -1094A/C polymorphism is not significantly associated with lupus disease susceptibility, albeit the role of NF-kappaB pathway in FasL promoter activation remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[The -1094A/C polymorphism is not significantly associated with lupus disease susceptibility, albeit the role of NF-kappaB pathway in FasL promoter activation remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP90301.RARZmA2SAANI7lLezpBcT_iBpelSh-WY5Ch01K02YMBvk130_assertion description "[The -1094A/C polymorphism is not significantly associated with lupus disease susceptibility, albeit the role of NF-kappaB pathway in FasL promoter activation remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90301.RARZmA2SAANI7lLezpBcT_iBpelSh-WY5Ch01K02YMBvk130_provenance.
- NP249001.RAvkeerDgnlYbE6mgmzCqdVSHnr5HE81I_WlvMx_78m84130_assertion description "[The -1094A/C polymorphism is not significantly associated with lupus disease susceptibility, albeit the role of NF-kappaB pathway in FasL promoter activation remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP249001.RAvkeerDgnlYbE6mgmzCqdVSHnr5HE81I_WlvMx_78m84130_provenance.
- NP249005.RAtJAs1hse4MNkj9f-sEEovDYkjJxJEz7gMCBFaQmOPCA130_assertion description "[The -1094A/C polymorphism is not significantly associated with lupus disease susceptibility, albeit the role of NF-kappaB pathway in FasL promoter activation remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP249005.RAtJAs1hse4MNkj9f-sEEovDYkjJxJEz7gMCBFaQmOPCA130_provenance.
- NP478256.RADkqZl_7ZuhalUKy6dHplNExnRebor5mP16xRq2y8Pg0130_assertion description "[The -1094A/C polymorphism is not significantly associated with lupus disease susceptibility, albeit the role of NF-kappaB pathway in FasL promoter activation remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478256.RADkqZl_7ZuhalUKy6dHplNExnRebor5mP16xRq2y8Pg0130_provenance.
- NP478253.RAeu_KJqo0tIw0I9LiePfabYl9eWQZjCooF9H9ZJ4-kNk130_assertion description "[The -1094A/C polymorphism is not significantly associated with lupus disease susceptibility, albeit the role of NF-kappaB pathway in FasL promoter activation remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478253.RAeu_KJqo0tIw0I9LiePfabYl9eWQZjCooF9H9ZJ4-kNk130_provenance.
- NP478255.RAYoiznjf4ng9PkXZPawoVBP6F6jvso5v3bpdwehtdFP0130_assertion description "[The -1094A/C polymorphism is not significantly associated with lupus disease susceptibility, albeit the role of NF-kappaB pathway in FasL promoter activation remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478255.RAYoiznjf4ng9PkXZPawoVBP6F6jvso5v3bpdwehtdFP0130_provenance.
- NP52525.RAx47hyLb_8Ouf1S_jxHBSb6LGDE52QsM0G85s8DzOmsk130_assertion description "[The -1094A/C polymorphism is not significantly associated with lupus disease susceptibility, albeit the role of NF-kappaB pathway in FasL promoter activation remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP52525.RAx47hyLb_8Ouf1S_jxHBSb6LGDE52QsM0G85s8DzOmsk130_provenance.
- NP249108.RADUmq6qM6uZzDouAAde980-egidJBOXdHQslLNUoDNUE130_assertion description "[The -1094A/C polymorphism is not significantly associated with lupus disease susceptibility, albeit the role of NF-kappaB pathway in FasL promoter activation remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP249108.RADUmq6qM6uZzDouAAde980-egidJBOXdHQslLNUoDNUE130_provenance.